| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Departments of Oncology,
Hubert H. Humphrey Center for Experimental Medicine and Cancer Research, Hebrew University-Hadassah Medical School, Jerusalem; and
Department of Biology, Technion, Israel Institute of Technology, Haifa, Israel
1Correspondence: Department of Oncology, Hadassah-University Hospital, POB 12000, Jerusalem 91120, Israel. E-mail: barshav{at}md.huji.ac.il
The formation of new blood vessels is a critical determinant of tumor progression. We find that Par1 gene expression plays a central role in blood vessel recruitment in animal models. By in vivo injection of either Matrigel plugs containing Par1-expressing cells or of rat prostatic carcinoma cells transfected with tetracycline-inducible Par1 expression vectors, we show that Par1 significantly enhances both angiogenesis and tumor growth. Several vascular endothelial growth factor (VEGF) splice forms are induced in cells expressing Par1. Activation of PAR1 markedly augments the expression of VEGF mRNAs and of functional VEGFs as determined by in vitro assays for endothelial tube alignment and bovine aortic endothelial cell proliferation. Because neutralizing anti-VEGF antibodies potently inhibited Par1-induced endothelial cell proliferation, we conclude that Par1-induced angiogenesis requires VEGF. Specific inhibitors of protein kinase C (PKC), Src, and phosphatidylinositol 3-kinase (PI3K) inhibit Par1-induced VEGF expression, suggesting the participation of these kinases in the process. We also show that oncogenic transformation by genes known to be part of PAR1 signaling machinery is sufficient to increase VEGF expression in NIH 3T3 cells. These data support the novel notion that initiation of cell signaling either by activating PAR1 or by the activated forms of oncogenes is sufficient to induce VEGF and hence angiogenesis. Yin, Y.-J., Salah, Z., Maoz, M., Cohen Even Ram, S., Ochayon, S., Neufeld, G., Katzav, S., Bar-Shavit, R. Oncogenic transformation induces tumor angiogenesis: a role for PAR1 activation.
Key Words: thrombin receptor • vascular endothelial growth factor • invasion • metastasis
This article has been cited by other articles:
|
|
 |
|
  H. H. Versteeg, F. Schaffner, M. Kerver, L. G. Ellies, P. Andrade-Gordon, B. M. Mueller, and W. Ruf Protease-Activated Receptor (PAR) 2, but not PAR1, Signaling Promotes the Development of Mammary Adenocarcinoma in Polyoma Middle T Mice Cancer Res., September 1, 2008; 68(17): 7219 - 7227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Mize, W. Wang, and T. K. Takayama Prostate-Specific Kallikreins-2 and -4 Enhance the Proliferation of DU-145 Prostate Cancer Cells through Protease-Activated Receptors-1 and -2 Mol. Cancer Res., June 1, 2008; 6(6): 1043 - 1051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I Jahan, J Fujimoto, S. M. Alam, E Sato, H Sakaguchi, and T Tamaya Role of protease activated receptor-2 in tumor advancement of ovarian cancers Ann. Onc., September 1, 2007; 18(9): 1506 - 1512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Arora, T. K. Ricks, and J. Trejo Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer J. Cell Sci., March 15, 2007; 120(6): 921 - 928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Salah, M. Maoz, E. Pokroy, M. Lotem, R. Bar-Shavit, and B. Uziely Protease-Activated Receptor-1 (hPar1), A Survival Factor Eliciting Tumor Progression Mol. Cancer Res., March 1, 2007; 5(3): 229 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Guo, J. Li, H. Wang, M. Osato, J. P. Tang, S. Y. Quah, B. Q. Gan, and Q. Zeng PRL-3 Initiates Tumor Angiogenesis by Recruiting Endothelial Cells In vitro and In vivo Cancer Res., October 1, 2006; 66(19): 9625 - 9635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nguyen, A. Kuliopulos, R. A. Graham, and L. Covic Tumor-Derived Cyr61(CCN1) Promotes Stromal Matrix Metalloproteinase-1 Production and Protease-Activated Receptor 1-Dependent Migration of Breast Cancer Cells. Cancer Res., March 1, 2006; 66(5): 2658 - 2665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Smadja, I. Bieche, G. Uzan, H. Bompais, L. Muller, C. Boisson-Vidal, M. Vidaud, M. Aiach, and P. Gaussem PAR-1 Activation on Human Late Endothelial Progenitor Cells Enhances Angiogenesis In Vitro With Upregulation of the SDF-1/CXCR4 System Arterioscler. Thromb. Vasc. Biol., November 1, 2005; 25(11): 2321 - 2327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Steinhoff, J. Buddenkotte, V. Shpacovitch, A. Rattenholl, C. Moormann, N. Vergnolle, T. A. Luger, and M. D. Hollenberg Proteinase-Activated Receptors: Transducers of Proteinase-Mediated Signaling in Inflammation and Immune Response Endocr. Rev., February 1, 2005; 26(1): 1 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ma, R. Perini, W. McKnight, M. Dicay, A. Klein, M. D. Hollenberg, and J. L. Wallace Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets PNAS, January 4, 2005; 102(1): 216 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Salah, M. Maoz, I. Cohen, G. Pizov, D. Pode, M. S. Runge, and R. Bar-Shavit Identification of a novel functional androgen response element within hPar1 promoter: implications to prostate cancer progression FASEB J, January 1, 2005; 19(1): 62 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Hazarika, M. F. McCarty, V. G. Prieto, S. George, D. Babu, D. Koul, M. Bar-Eli, and M. Duvic Up-regulation of Flotillin-2 Is Associated with Melanoma Progression and Modulates Expression of the Thrombin Receptor Protease Activated Receptor 1 Cancer Res., October 15, 2004; 64(20): 7361 - 7369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Moreno, S. Ramachandran, D. G. Ashby, N. Laycock, C. A. Plattner, W. Chen, W. C. Hahn, and D. C. Pallas Signaling and Transcriptional Changes Critical for Transformation of Human Cells by Simian Virus 40 Small Tumor Antigen or Protein Phosphatase 2A B56{gamma} Knockdown Cancer Res., October 1, 2004; 64(19): 6978 - 6988. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Shi, B. Gangadharan, L. F. Brass, W. Ruf, and B. M. Mueller Protease-Activated Receptors (PAR1 and PAR2) Contribute to Tumor Cell Motility and Metastasis Mol. Cancer Res., July 1, 2004; 2(7): 395 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Minami, A. Sugiyama, S.-Q. Wu, R. Abid, T. Kodama, and W. C. Aird Thrombin and Phenotypic Modulation of the Endothelium Arterioscler. Thromb. Vasc. Biol., January 1, 2004; 24(1): 41 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-J. Yin, Z. Salah, S. Grisaru-Granovsky, I. Cohen, S. C. Even-Ram, M. Maoz, B. Uziely, T. Peretz, and R. Bar-Shavit Human Protease-Activated Receptor 1 Expression in Malignant Epithelia: A Role in Invasiveness Arterioscler. Thromb. Vasc. Biol., June 1, 2003; 23(6): 940 - 944. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
